Loading menubar.....

Difference between revisions of "Team:Tuebingen/einweiterer"

 
(6 intermediate revisions by the same user not shown)
Line 29: Line 29:
 
             margin-left: 30%;
 
             margin-left: 30%;
 
             margin-top: 15%;
 
             margin-top: 15%;
          position: center;
 
 
         }
 
         }
  
Line 1,715: Line 1,714:
 
         .offset-xl-11 {
 
         .offset-xl-11 {
 
             margin-left: 91.666667%
 
             margin-left: 91.666667%
 +
        }
 +
    }
 +
 +
    .veggie {
 +
        width: 100%;
 +
        max-width: 100%;
 +
        margin-bottom: 1rem;
 +
        background-color: transparent;
 +
        z-index:100;
 +
    }
 +
    .veggie td,
 +
    .veggie th {
 +
        padding: .75rem;
 +
        vertical-align: top;
 +
        border-top: 1px solid #F4F0DE;
 +
        color: #F4F0DE;
 +
        border-bottom: 1px solid #F4F0DE;
 +
        z-index:100;
 +
    }
 +
    .veggie th {
 +
        background-color: #2ecc71 !important;
 +
        color: #232323 !important;
 +
        z-index:100;
 +
    }
 +
    .veggie caption {
 +
        color: #adb3b7;
 +
        z-index:100;
 +
    }
 +
    .veggie thead th {
 +
        vertical-align: bottom;
 +
        border-bottom: 2px solid #dee2e6;
 +
        z-index:100;
 +
    }
 +
    .veggie tbody+tbody {
 +
        border-top: 2px solid #dee2e6;
 +
        z-index:100;
 +
    }
 +
 +
    @media screen and (max-width: 800px) {
 +
        .veggie {
 +
            font-size: xx-small;
 +
            z-index:100;
 
         }
 
         }
 
     }
 
     }
Line 1,917: Line 1,958:
 
             display: block;
 
             display: block;
 
             width: 100%;
 
             width: 100%;
             overflow-x: auto;
+
             overflow-x: break-words;
 
             -webkit-overflow-scrolling: touch;
 
             -webkit-overflow-scrolling: touch;
 
             -ms-overflow-style: -ms-autohiding-scrollbar
 
             -ms-overflow-style: -ms-autohiding-scrollbar
Line 1,931: Line 1,972:
 
             display: block;
 
             display: block;
 
             width: 100%;
 
             width: 100%;
             overflow-x: auto;
+
             overflow-x: break-words;
 
             -webkit-overflow-scrolling: touch;
 
             -webkit-overflow-scrolling: touch;
 
             -ms-overflow-style: -ms-autohiding-scrollbar
 
             -ms-overflow-style: -ms-autohiding-scrollbar
Line 1,945: Line 1,986:
 
             display: block;
 
             display: block;
 
             width: 100%;
 
             width: 100%;
             overflow-x: auto;
+
             overflow-x: break-words;
 
             -webkit-overflow-scrolling: touch;
 
             -webkit-overflow-scrolling: touch;
 
             -ms-overflow-style: -ms-autohiding-scrollbar
 
             -ms-overflow-style: -ms-autohiding-scrollbar
Line 6,035: Line 6,076:
  
 
     .bg-dark {
 
     .bg-dark {
         background-color: #343a40 !important
+
         background-color: #232323 !important
 
     }
 
     }
  
Line 9,284: Line 9,325:
  
 
     .dropdown-menu {
 
     .dropdown-menu {
         background-color: rgba(100, 100, 100, 1);
+
         background-color: #232323;
 
     }
 
     }
  
Line 10,241: Line 10,282:
 
                 <li id="ourStoryButton" class="nav-item mx-3">
 
                 <li id="ourStoryButton" class="nav-item mx-3">
 
                     <a class="nav-link" href="/Team:Tuebingen/Story"
 
                     <a class="nav-link" href="/Team:Tuebingen/Story"
                       style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">OUR STORY</a>
+
                       style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">OUR
 +
                        STORY</a>
 
                 </li>
 
                 </li>
  
Line 10,258: Line 10,300:
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Incretin"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Incretin"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Incretin</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Incretin</a>
                         <a class="dropdown-item" href="/Team:Tuebingen/CPP"
+
                         <a class="dropdown-item" href="/Team:Tuebingen/Model"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Cell Penetrating Peptides</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Software"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Software</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Results"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Results"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Results</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Results</a>
Line 10,266: Line 10,310:
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Notebook"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Notebook"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Notebook</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Notebook</a>
                        <a class="dropdown-item" href="/Team:Tuebingen/Model"
 
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
 
                        <a class="dropdown-item" href="/Team:Tuebingen/Software"
 
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Software</a>
 
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Outlook"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Outlook"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Outlook</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Outlook</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Entrepreneurship</a>
 
                     </div>
 
                     </div>
 
                 </li>
 
                 </li>
Line 10,281: Line 10,323:
 
                     <div class="dropdown-menu">
 
                     <div class="dropdown-menu">
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Parts"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Parts"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Parts Overview</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Parts
 +
                            Overview</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Basic_Part"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Basic_Part"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Basic Parts</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Basic
 +
                            Parts</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Improved_Part"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Improved_Part"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Improved Parts</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Improved
 +
                            Parts</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Characterized_Part"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Improved
 +
                            Parts</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Composite_Part"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Composite_Part"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Composite Parts</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Composite
 +
                            Parts</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Part_Collection"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Part_Collection"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Part Collection</a>
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Part
 +
                            Collection</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Downloads"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Downloads</a>
 
                     </div>
 
                     </div>
 
                 </li>
 
                 </li>
Line 10,303: Line 10,355:
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Collaborations"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Collaborations"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Collaborations</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Collaborations</a>
                        <a class="dropdown-item" href="/Team:Tuebingen/Attributions"
 
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Attributions</a>
 
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Sponsors"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Sponsors"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sponsors</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sponsors</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Attributions"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Attributions</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Gallery"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Gallery"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Gallery</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Gallery</a>
Line 10,321: Line 10,373:
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Overview</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Overview</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public Engagement</a>
                            Engagement</a>
+
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Experts"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Experts"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experts</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experts</a>
                        <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
 
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Entrepreneurship</a>
 
 
                         <a class="dropdown-item" href="/Team:Tuebingen/SDG"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/SDG"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sustainable Development
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Sustainable Development Goals</a>
                            Goals</a>
+
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Experimenta"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Experimenta"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experimenta Science
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Experimenta
                             Center</a>
+
                             Science Center</a>
 +
                        <a class="dropdown-item" href="/Team:Tuebingen/Survey"
 +
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Survey</a>
 
                     </div>
 
                     </div>
 
                 </li>
 
                 </li>
Line 10,344: Line 10,394:
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Integrated Human Practise</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Integrated Human Practise</a>
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Public_Engagement"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Education & Public Engagement</a>
                            Engagement</a>
+
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Entrepreneurship"
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Supporting
+
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Supporting Entrepreneurship</a>
                            Entrepreneurship</a>
+
                        <a class="dropdown-item" href="/Team:Tuebingen/Measurement"
+
                          style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Measurement</a>
+
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Model"
 
                         <a class="dropdown-item" href="/Team:Tuebingen/Model"
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
 
                           style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">Model</a>
Line 10,365: Line 10,411:
 
                 <li class="nav-item mx-3">
 
                 <li class="nav-item mx-3">
 
                     <a class="nav-link" href="https://igem.org/2019_Judging_Form?team=Tuebingen" target="_blank"
 
                     <a class="nav-link" href="https://igem.org/2019_Judging_Form?team=Tuebingen" target="_blank"
                       style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">JUDGING
+
                       style="font-family: 'Righteous', cursive; font-weight: normal; color: #2ecc71;">JUDGING FORM ⇗</a>
                        FORM ⇗</a>
+
 
                 </li>
 
                 </li>
  
Line 10,576: Line 10,621:
 
         -webkit-transform: translateZ(0) scale(1.0, 1.0);
 
         -webkit-transform: translateZ(0) scale(1.0, 1.0);
 
         transform: translateZ(0);
 
         transform: translateZ(0);
         background: #1B2030 url(https://2019.igem.org/wiki/images/a/a0/T--Tuebingen--description-banner.jpg) center no-repeat;
+
         background: #1B2030 url(https://2019.igem.org/wiki/images/5/50/T--Tuebingen--experimenta-banner.jpg) center no-repeat;
 
         background-size: 100%, 100%;
 
         background-size: 100%, 100%;
 
         animation: grow 30s linear 10ms infinite;
 
         animation: grow 30s linear 10ms infinite;
Line 10,638: Line 10,683:
 
         }
 
         }
  
        .header {
 
            height:40vh
 
        }
 
    }
 
  
    @media only screen and (max-width: 600px) {
 
        .header {
 
            height:35vh
 
        }
 
 
     }
 
     }
 +
 +
  
 
     @media only screen and (max-width: 560px) {
 
     @media only screen and (max-width: 560px) {
Line 10,653: Line 10,692:
 
             margin-top: 15%;
 
             margin-top: 15%;
 
         }
 
         }
    }
 
 
    @media only screen and (max-width: 500px) {
 
 
         .header {
 
         .header {
             height:30vh
+
             height: 40vh;
 
         }
 
         }
 
     }
 
     }
 +
 +
  
 
     @media only screen and (max-width: 470px) {
 
     @media only screen and (max-width: 470px) {
Line 10,668: Line 10,706:
 
     }
 
     }
  
    @media only screen and (max-width: 450px) {
+
 
        .header {
+
            height:25vh
+
        }
+
    }
+
  
 
     @media only screen and (max-width: 400px) {
 
     @media only screen and (max-width: 400px) {
 
         .info h1 {
 
         .info h1 {
             margin-top: 15%;
+
             margin-top: 20%;
 +
        }
 +
        .header {
 +
            height: 27vh;
 
         }
 
         }
 
     }
 
     }
Line 10,682: Line 10,719:
 
     @media only screen and (max-width: 350px) {
 
     @media only screen and (max-width: 350px) {
 
         .info h1 {
 
         .info h1 {
             margin-top: 18%;
+
             margin-top: 25%;
 
         }
 
         }
 
     }
 
     }
Line 10,705: Line 10,742:
 
<div class="header">
 
<div class="header">
 
   <div class="info">
 
   <div class="info">
     <h1 style="font-family: 'Righteous', cursive; font-weight: normal; color:#2ecc71;">Notebook</h1>
+
     <h1 style="font-family: 'Righteous', cursive; font-weight: normal; color:#2ecc71;">Experimenta</h1>
 
   </div>
 
   </div>
 
</div>
 
</div>
Line 10,711: Line 10,748:
  
  
<div style="background-color: #232323; overflow-x: fragments; overflow-wrap: inherit">
+
<div style="background-color: #232323; overflow-x: fragments; overflow-wrap: break-word">
  
 
<div class="glpContainer">
 
<div class="glpContainer">
Line 10,723: Line 10,760:
 
         <div id="image-popups">
 
         <div id="image-popups">
  
            <div class="container-fluid py-5 mb-0" style="background-color: #232323"> <!-- FOR REUSE: REMOVE bg-dark IF U DONT WANNA HAVE A DARK BACKGROUND -->
+
        <h2 style="font-family:'Righteous'; color:#2ecc71;">The Experimenta Science Center Heilbronn</h2>
<div id="accordion">
+
        <div class="row">
  <div class="card">
+
            <div class="col-12">
    <div class="card-header" id="headingOne">
+
                <p>
      <h5 class="mb-0">
+
                    The Experimenta Science Center (<a href="https://www.experimenta.science/" onclick='window.open("https://www.experimenta.science/","_self");'>Experimenta</a>) in Heilbronn, Baden-Wuerttemberg,
        <button class="btn btn-one btn-link collapsed" data-toggle="collapse" data-target="#collapseOne" aria-expanded="false" aria-controls="collapseOne">
+
                    Germany offers science at your fingertips on an area of around 25,000 square metres with around 275
          Week 1 (08 Jul - 12 Jul)
+
                    interactive exhibits, four creative studios and nine laboratories, as well as an observatory and an
        </button>
+
                    extraordinary science dome with spectacular science shows. Additionally, last year, they set up the
      </h5>
+
                    “Schülerforschungszentrum” (SFZ), where young researchers are actively supported in their initial
    </div>
+
                    scientific work. It is directed at students from high schools in Heilbronn. Their general idea is to
    <div id="collapseOne" class="collapse" aria-labelledby="headingOne" data-parent="#accordion" >
+
                    encourage students to develop their own projects while funding, lab space and supervision is granted.
      <div class="card-body" style="background-color: #232323;">
+
                </p>
          <p style="color: #F4F0DE">
+
            </div>
              08 Jakob, Patrick, Eva After moving into our new lab and settling in, first practical
+
        </div>
              steps like aliquoting our primers or preparing LB-Medium and LB-Agar were taken.
+
 
              09 Jakob, Patrick, Eva We amplified Cas 3 out of E.Coli gDNA via PCR (Q5 Polymerase)
+
            <h2 style="font-family:'Righteous'; color:#2ecc71;">Our 4 Day Lab Course</h2>
              and transformed the biobricks BBa_K608351 (K2), BBa_K091001 (K5), BBa_I13453 (K10),
+
            <div class="row">
              BBa_K584000 (AraC Promotor), BBa_K117008 (LsrR Promotor), BBa_R0073 (Mnt Promotor) in
+
                <div class="col-12">
              competent E. Coli DH5-alpha (NEB iGEM Kit). 10 Eva, Patrick We amplified Cascade out of
+
                    <p>The course was held in a collaborative manner over a span of four days. Dr. Robert Friedrich,
              E.Coli MG1655 gDNA via PCR (Q5 Polymerase) and checked the Cas 3 and Cascade PCRs via agarose
+
                        a biologist working for the SFZ, gave the general lab introduction and provided the overall lab
              gel electrophoresis. (figure 1) We picked colonies for all but the Ba_K608351 (K2)
+
                        responsibility, while we were mainly responsible to teach the required theoretical background,
              transformations (no growth) for inoculating overnight cultures and made a new batch of
+
                        introduce bioinformatics data analysis (DNA-Seq) and finally project development. Additionally,
              competent E.Coli Dh-5α cells. 11 Jakob, Eva, Patrick By Miniprep (Qiagen) we extracted the
+
                        we were supporting Dr. Friedrich during the experiments and closely supervised the students.</p>
              DNA of the overnight cultures. Amplification via PCR (Q5 Polymerase) of Cascade was repeated
+
                </div>
              (figure 2). BBa_K608351 (K2) was transformed again and the competent cells tested.
+
            </div>
          </p>
+
            <div class="row">
          <figure>
+
                <div class="col-12">
 +
                    <div class="row align-items-center">
 +
        <div class="col-12 col-md-6">
 +
        <figure>
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/a/a8/T--Tuebingen--Gel1.png"
+
                           href="https://2019.igem.org/wiki/images/e/e8/T--Tuebingen--Experimenta-Lab4.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/a/a8/T--Tuebingen--Gel1.png"
+
                             <img src="https://2019.igem.org/wiki/images/e/e8/T--Tuebingen--Experimenta-Lab4.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder"></a>
+
                                 alt="Placeholder"></a>
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 1. 17/10/19 Gelelctrophoresis of Cas 3 and Cascade PCR. Gel loaded (from left to right):
+
                     </figure>
                        Ladder 1kb, Cas 3 (72°C), Cas 3 (68°C), H2O, Cascade (72°C), Cascade (68°C), H2O. It shows positive
+
 
                        PCR of Cas 3 (68°C), expected at ~2.7 kb.</figcaption>
+
        </div>
          </figure>
+
        <div class="col-12 col-md-6 ">
          <figure>
+
        <p>We conveyed the required theoretical background in a modern and interactive way, with the use of
 +
            smart boards and current web tools. We focused on teaching the highly motivated students cutting-edge
 +
            research, while providing a theoretical foundation, preparing them for different biology competitions
 +
            and eventually university.</p>
 +
        </div>
 +
                    </div>
 +
                </div>
 +
            </div>
 +
 
 +
            <div class="row">
 +
                <div class="col-12">
 +
                    <div class="row align-items-center">
 +
        <div class="col-12 col-md-6">
 +
        <figure>
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/2/2a/T--Tuebingen--Gel2.png"
+
                           href="https://2019.igem.org/wiki/images/9/94/T--Tuebingen--Experimenta-Lab3.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/2/2a/T--Tuebingen--Gel2.png"
+
                             <img src="https://2019.igem.org/wiki/images/9/94/T--Tuebingen--Experimenta-Lab3.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder image"></a>
+
                                 alt="Placeholder"></a>
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 2. 07/11/19 Gelelctrophoresis of Cascade PCR. Gel loaded (from left to right):
+
                     </figure>
                        Ladder 1kb, Cascade (68°C), Cascade (64°C). It shows positive PCR of Cas 3 (68°C), expected at ~4.4 kb.</figcaption>
+
 
          </figure>
+
        </div>
      </div>
+
        <div class="col-12 col-md-6 ">
    </div>
+
         <figure>
  </div>
+
</div>
+
                <div id="accordion2">
+
  <div class="card">
+
    <div class="card-header" id="headingOne">
+
      <h5 class="mb-0">
+
        <button class="btn btn-one btn-link collapsed" data-toggle="collapse" data-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
+
          Week 2 (15 Jul - 19 Jul)
+
         </button>
+
      </h5>
+
    </div>
+
    <div id="collapseTwo" class="collapse" aria-labelledby="headingTwo" data-parent="#accordion2" >
+
      <div class="card-body" style="background-color: #232323;">
+
          <p style="color: #F4F0DE">
+
              15 Jakob Patrick Eva Luzi The biobricks were transformed again. Cascade and Cas 3 PCR products were
+
              sent off for Sanger sequencing.
+
              16 Patrick, Eva Since there repeatedly weren’t any colonies for BBa_K608351 (K2), we transformed it
+
              in provided NovaBlue™ competent cells. Overnight cultures of the other biobricks as well as an
+
              overnight culture of E.Coli Nissle were inoculated. 17 Eva Patrick Katharina Glycerol
+
              stocks of the overnight cultures were prepared. Competent E. Coli Nissle cells were produced and
+
              the growth of E. Coli Nissle was analysed preliminarily. After Miniprep (Qiagen) of BBa_K516030 (RFP)
+
              a PCR (Pfu Polymerase) was run. After digestion of the PCR products Cas 3 and Cascade as well as the
+
              plasmid BBa_I13453 (K10), K10_Cascade and K10_Cas3 were ligated. 18 Eva Patrick The K10_Cascade and
+
              K10_Cas3 ligations were digested (single) and analysed by gel electrophoresis, together with the RFP
+
              PCR product (figure 3). The gel did not show a result for K10_Cascade and K10_Cas3. RFP (PCR Product)
+
              and BBa_R0073 (Mnt Promotor) were digested and ligated. 19 Eva Patrick Digestion and Ligation of Cascade,
+
              Cas3 and K10 were repeated with increased amounts of DNA. K10_Cascade, K10_Cas3 and BBa_R0073(Mnt)_RFP
+
              were transformed.
+
          </p>
+
          <figure>
+
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/3/30/T--Tuebingen--Gel3.png"
+
                           href="https://2019.igem.org/wiki/images/6/69/T--Tuebingen--Experimenta-Lab5.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/3/30/T--Tuebingen--Gel3.png"
+
                             <img src="https://2019.igem.org/wiki/images/6/69/T--Tuebingen--Experimenta-Lab5.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder"></a>
+
                                 alt="Placeholder"></a>
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 3. 07/18/19 Gelelctrophoresis of
+
                     </figure>
                        RFP PCR, digests of K10_Cascade and K10_Cas3. Gel loaded (from left to right): Ladder 1 kb,
+
        </div>
                        RFP 1, RFP 2, RFP 3, K10_Cas3 (no heat inact.), K10_Cas3, K10_Cascade, Ladder 1 kb. It shows
+
                    </div>
                        positive PCR of RFP, expected at ~890 bp. No result for digestions.</figcaption>
+
                    <p>
          </figure>
+
                        Please check out the material we prepared for the course - a script covering all the theoretical
      </div>
+
                        background and a presentation:
    </div>
+
                    </p>
  </div>
+
                    <ul style="color:#F4F0DE;">
</div>
+
                      <li><a href="https://2019.igem.org/wiki/images/6/6c/T--Tuebingen--Experimenta_Labkurs_Skript.pdf" onclick='window.open("https://2019.igem.org/wiki/images/6/6c/T--Tuebingen--Experimenta_Labkurs_Skript.pdf","_self");'>Experimenta Labkurs</a></li>
                <div id="accordion3">
+
                      <li><a href="https://2019.igem.org/wiki/images/1/10/T--Tuebingen--LabCoursePresentation.pdf" onclick='window.open("https://2019.igem.org/wiki/images/1/10/T--Tuebingen--LabCoursePresentation.pdf","_self");'>LabCourse Presentation</a>)</li>
  <div class="card">
+
                    </ul>
    <div class="card-header" id="headingThree">
+
                    <p>
      <h5 class="mb-0">
+
                        Please see the schedule below.
        <button class="btn btn-one btn-link collapsed" data-toggle="collapse" data-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree">
+
                    </p>
          Week 3 (22 Jul - 26 Jul)
+
                </div>
        </button>
+
            </div>
      </h5>
+
 
    </div>
+
            <div class="row">
    <div id="collapseThree" class="collapse" aria-labelledby="headingThree" data-parent="#accordion3" >
+
                <div class="col-12">
      <div class="card-body" style="background-color: #232323;">
+
                    <figure>
          <p style="color: #F4F0DE">
+
              23 Eva Jakob Patrick Preparation of LB-Medium, LB-Agar and Chloramphenicol plates. Overnight cultures
+
              for K10_Cascade, K10_Cas3 and BBa_R0073(Mnt)_RFP colonies were inoculated. After double digestion of
+
              BBa_K584000 (AraC Promotor), BBa_K117008 (LsrR Promotor), the fragments pAraC and pLsrR were extracted
+
              from the gel. 24 Eva Patrick After Miniprep of K10_Cascade, K10_Cas3 and BBa_R0073(Mnt)_RFP (Qiagen)
+
              the plasmids were single digested. Gelelectrophoresis showed the empty backbone (figure 4).
+
              The isolated fragments pAraC and pLsrR were ligated into the backbone psB1K3 after digestion.
+
              psBIK3_pAraC and psBIK3_pLsrR were transformed. 25 Eva Overnight cultures for psBIK3_pAraC and psBIK3_pLsrR
+
              colonies were inoculated. 26 Eva After Miniprep (Qiagen) of psBIK3_pAraC and psBIK3_pLsrR, the plasmids
+
              were digested. Gel electrophoresis showed successful ligations (figure 5).
+
          </p>
+
          <figure>
+
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/1/13/T--Tuebingen--Gel4.png"
+
                           href="https://2019.igem.org/wiki/images/f/f1/T--Tuebingen--table_test.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/1/13/T--Tuebingen--Gel4.png"
+
                             <img src="https://2019.igem.org/wiki/images/f/f1/T--Tuebingen--table_test.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder"></a>
+
                                 alt="Placeholder"></a>
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 4. 07/24/19 Single digestions after
+
                     </figure>
                        Miniprep. Gel loaded (from left to right): Ladder 1kb, BBa_R0073(Mnt)_RFP 1.1, BBa_R0073(Mnt)_RFP
+
                </div>
                         1.2, K10_Cas3 1.1-3.2, K10_Cascade 1.1-3.2. BBa_R0073(Mnt)_RFP expected at ~3 kb, K10_Cas 3 expected
+
            </div>
                        at ~4.9 kb, K10_Cascade expected at ~6.6 kb.</figcaption>
+
 
          </figure>
+
            <div class="row">
          <figure>
+
                <div class="col-12">
 +
                    <p>Due to the interactive design of the course, we also discussed the experiments with the students
 +
                         and tried to summarize what we did on the blackboard:</p>
 +
 
 +
                    <div class="row align-items-center">
 +
        <div class="col-12 col-md-6">
 +
        <figure>
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/b/b6/T--Tuebingen--Gel5.png"
+
                           href="https://2019.igem.org/wiki/images/b/be/T--Tuebingen--Experimenta-Lab1.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/b/b6/T--Tuebingen--Gel5.png"
+
                             <img src="https://2019.igem.org/wiki/images/b/be/T--Tuebingen--Experimenta-Lab1.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder image"></a>
+
                                 alt="Placeholder"></a>
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 5. 07/26/19 Single Digestions after
+
                     </figure>
                        Miniprep. Gel loaded (from left to right): psBIK3_pAraC 1-8, psB1K3_pLsrR 1-8, Ladder 1kb,
+
 
                        psB1K3 2.2-2.3, 3.1-3.2. Bands of ~3 kb suggest successful ligations.</figcaption>
+
        </div>
          </figure>
+
        <div class="col-12 col-md-6 ">
      </div>
+
         <figure>
    </div>
+
  </div>
+
</div>
+
                <div id="accordion4">
+
  <div class="card">
+
    <div class="card-header" id="headingFour">
+
      <h5 class="mb-0">
+
        <button class="btn btn-one btn-link collapsed" data-toggle="collapse" data-target="#collapseFour" aria-expanded="false" aria-controls="collapseFour">
+
          Week 4 (29 Jul - 02 Aug)
+
         </button>
+
      </h5>
+
    </div>
+
    <div id="collapseFour" class="collapse" aria-labelledby="headingFour" data-parent="#accordion4" >
+
      <div class="card-body" style="background-color: #232323;">
+
          <p style="color: #F4F0DE">
+
              30 Patrick, Katharina The team moved into a new laboratory. The synthesized sequences
+
              (K0, K3, K4, K6, K7, K15) arrived and were aliquoted. Chloramphenicol plates were prepared.
+
              Cascade, Cas3,  BBa_I13453 (K10), RFP and BBa_R0073 (Mnt Promotor) digestions and ligations were
+
              repeated and transformed. 31 Patrick Jakob Overnight cultures for K10_Cas3 colonies were inoculated,
+
              there was no growth of the other transformations. A PCR (Pfu polymerase) was run on the synthesized
+
              constructs, it wasn’t successful. The Minipreps of psBIK3_pAraC and psBIK3_pLsrR were used for retransformation.
+
              01 Patrick The K10_Cas3 overnight culture was miniprepped. Overnight cultures for psBIK3_pAraC, psBIK3_pLsrR,
+
              as well as K10_Cascade and BBa_R0073(Mnt)_RFP (some late colonies grew) were inoculated.
+
              02 Patrick Glycerol stocks for psBIK3_pAraC were prepared, there was no growth in psBIK3_pLsrR overnight
+
              cultures. After Miniprep of rpsBIK3_pAraC, K10_Cascade and BBa_R0073(Mnt)_RFP the plasmids (also K10_Cas3)
+
              were digested and a gel ectrophoresis was run. It showed the transformation of empty backbone in K10_Cascade
+
              and BBa_R0073(Mnt)_RFP, successful ligation for psBIK3_pAraC and XY for K10_Cas3 (figure 6).
+
          </p>
+
          <figure>
+
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/8/82/T--Tuebingen--Gel6.png"
+
                           href="https://2019.igem.org/wiki/images/d/df/T--Tuebingen--Experimenta-Lab2.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/8/82/T--Tuebingen--Gel6.png"
+
                             <img src="https://2019.igem.org/wiki/images/d/df/T--Tuebingen--Experimenta-Lab2.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder"></a>
+
                                 alt="Placeholder"></a>
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 6. 08/02/19 Digestions after Miniprep.
+
                     </figure>
                        Gel loaded (from left to right): Ladder 1 kb, K10_Cas3 1-10, K10_Cascade 1-4, BBa_R0073(Mnt)_RFP 1-2,
+
        </div>
                        positive control, psBIK3_pAraC. Negative results for K10_Cas3, expected at ~4.9 kb, and K10_Cascade,
+
                    </div>
                        expected at 6.6 kb. Successful ligation of psBIK3_pAraC, ~ 3 kb.</figcaption>
+
                </div>
          </figure>
+
            </div>
      </div>
+
 
    </div>
+
            <div class="row">
  </div>
+
                <div class="col-12">
</div>
+
                    <p>The students were also very interested in iGEM and our work. Hence, we not only introduced iGEM
                <div id="accordion5">
+
                        and our project to them, but also let them critically evaluate our project. They were also given
  <div class="card">
+
                        the chance to conduct PCRs related to our project and could therefore gain insights into the upcoming
    <div class="card-header" id="headingFive">
+
                        challenges when starting a new project or experiment where not everything has been optimised for
      <h5 class="mb-0">
+
                        easy functionality. Many students were interested in the iGEM competition itself and in the process
        <button class="btn btn-one btn-link collapsed" data-toggle="collapse" data-target="#collapseFive" aria-expanded="false" aria-controls="collapseFive">
+
                        of finding a project and making it feasible. Therefore, we also invested into giving valuable input
          Week 5 (05 Aug - 09 Aug)
+
                        and advice on starting a project and encouraged the students to participate in iGEM or similar projects
        </button>
+
                        themselves. Several questions and concerns relating the functionality of our probiotic under different
      </h5>
+
                        conditions, such as patients taking medications or antibiotics were also raised by the students. These
    </div>
+
                        fruitful discussions, as well as our exchange with several experts, contributed to the final design
    <div id="collapseFive" class="collapse" aria-labelledby="headingThree" data-parent="#accordion5" >
+
                        of our RNA-Seq experiment providing valuable input and different aspects to be considered
      <div class="card-body" style="background-color: #232323;">
+
                        [<a href="https://2019.igem.org/Team:Tuebingen/Experts" onclick='window.open("https://2019.igem.org/Team:Tuebingen/Experts","_self");'>Experts</a>, <a href="https://2019.igem.org/Team:Tuebingen/Nissle" onclick='window.open("https://2019.igem.org/Team:Tuebingen/Nissle","_self");'>Nissle</a>].</p>
          <p style="color: #F4F0DE">
+
 
              05 Patrick Eva Antonia PCR (Q5 polymerase) and PCR (Paq polymerase) was run on the synthesized constructs,
+
                    <p>
              they weren’t successful. Cascade and Cas3 were successfully amplified via PCR(Q5). 06 Eva Patrick Antonia
+
                        Due to the high interest of the students and the positive feedback from the Experimenta itself,
              A gradient PCR (Q5) was run on the constructs. It was discovered that the currently used agarose was falsely
+
                        we discussed the possibility of creating an iGEM high school team in Heilbronn in 2020.
              prepared with water instead of TAE-Buffer and was discarded. Cascade, Cas3 and BBa_I13453 (K10) were
+
                        The Experimenta is highly interested in participating in iGEM 2020 with motivated students and
              digested and ligated. 07 Patrick Eva Luzi Antonia A new PCR (Q5) was run on the synthesized constructs,
+
                        will provide the required laboratories, supervision and funding. Our team will still be serving
              gelectrophoresis suggested positive apmlification (figure 7). By amplification with accordingly designed primer,
+
                        as advisors for the planned iGEM high school team next year. Furthermore, a new student lab course
              K0 has been added a TetR promotor and is now K1. Due to a technical malfunction in the building further
+
                        on CRISPR/Cas will be introduced at the Experimenta on the grounds of the theoretical background,
              work was delayed.
+
                        input and inspiration iGEM Tuebingen conveyed.
          </p>
+
                    </p>
          <figure>
+
                </div>
 +
            </div>
 +
 
 +
            <h3 style="font-family:'Righteous'; color:#2ecc71;">Panel Discussion - „Biohacking – genetic experiments done at home“</h3>
 +
            <div class="row">
 +
                <div class="col-12">
 +
                    <p>In addition to the lab course, we also decided to host a panel discussion at the Experimenta.
 +
                        At the beginning of the <a href="https://2019.igem.org/wiki/images/2/24/T--Tuebingen--panelDiscussion.pdf" onclick='window.open("https://2019.igem.org/wiki/images/2/24/T--Tuebingen--panelDiscussion.pdf","_self");'>panel discussion</a>, we gave a talk about on the CRISPR / Cas method itself.
 +
                        We also included an overview of our ongoing project and the iGEM competition in general.</p>
 +
 
 +
                    <p>
 +
                        In collaboration with Dr. Robert Friedrich, we designed a discussion around the status of current
 +
                        research on CRISPR / Cas, the effectiveness of the method and its limitations, the prospects of
 +
                        future CRISPR / Cas developments, the availability and legality of so-called Do-It-Yourself CRISPR /
 +
                        Cas Kits and the ethical implications on society. The panel consisted out of Prof. Dr. Christoph
 +
                        Thyssen (<a href="www.bio.uni-kl.de/organisation/mitarbeiter/s-u/thyssen-christoph/" onclick='window.open("www.bio.uni-kl.de/organisation/mitarbeiter/s-u/thyssen-christoph/","_self");'>Christoph Thyssen</a>), an expert for subject
 +
                        didactics in biology and two of our team members - Marietheres Evers and Famke Baeuerle.
 +
                    </p>
 +
 
 +
                    <div class="row align-items-center">
 +
        <div class="col-12 col-md-6">
 +
        <figure>
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/4/46/T--Tuebingen--Gel7.png"
+
                           href="https://2019.igem.org/wiki/images/5/54/T--Tuebingen--Biohacking_05.jpg"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/4/46/T--Tuebingen--Gel7.png"
+
                             <img src="https://2019.igem.org/wiki/images/5/54/T--Tuebingen--Biohacking_05.jpg"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder"></a>
+
                                 alt="Placeholder"></a>
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 7. 08/08/19 PCR of synthesized constructs.
+
                     </figure>
                        Gel loaded (from left to right): Ladder 1kb, K1 (expected at 660bp), K3 (expected at 1 kb),
+
 
                        K4 (expected at 1 kb), K6 (expected at 1.5 kb), K7 (expected at 700 bp), K15 (expected at 1 kb).</figcaption>
+
        </div>
          </figure>
+
        <div class="col-12 col-md-6 ">
      </div>
+
         <figure>
    </div>
+
  </div>
+
</div>
+
                <div id="accordion6">
+
  <div class="card">
+
    <div class="card-header" id="headingSix">
+
      <h5 class="mb-0">
+
        <button class="btn btn-one btn-link collapsed" data-toggle="collapse" data-target="#collapseSix" aria-expanded="false" aria-controls="collapseSix">
+
          Week 6 (12 Aug - 16 Aug)
+
         </button>
+
      </h5>
+
    </div>
+
    <div id="collapseSix" class="collapse" aria-labelledby="headingSix" data-parent="#accordion6" >
+
      <div class="card-body" style="background-color: #232323;">
+
          <p style="color: #F4F0DE">
+
              12 Patrick Katharina After respective digestion and DNA clean up, psBC13_K1, psBC13_K3, psBC13_K6, K5_K4,
+
              K10_Cas3, K10_Cascade and BBa_R0073(Mnt)_RFP were ligated. 13 Patrick Eva Antonia Marie Yesterday’s ligations
+
              were transformed. 14 Luzie Marie Eva A colony PCR (Taq polymerase) was run on psBC13_K1,
+
              but the gelelectrophoresis was negative (figure 8). Overnight cultures of psBC13_K1, psBC13_K3, psBC13_K6,
+
              K5_K4, K10_Cas3 and K10_Cascade colonies were inoculated. 15 Marie Patrick Eva After Miniprep the plasmids
+
              were double digested. Gel electrophoresis suggested successful ligations of psBC13_K6, K10_Cas3, K10_Cascade
+
              and BBa_R0073(Mnt)_RFP (figure 9). 16 Patrick Miniprep of psBC13_K1 was digested but gelectrophoresis was negative.
+
              Cascade and Cas3 were amplified by PCR (Q5 polymerase). The synthesized construct K2 arrived, was diluted and
+
              amplified via PCR (Q5 polymerase).
+
          </p>
+
          <figure>
+
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/2/25/T--Tuebingen--Gel8.png"
+
                           href="https://2019.igem.org/wiki/images/4/4d/T--Tuebingen--Biohacking_10.jpg"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/2/25/T--Tuebingen--Gel8.png"
+
                             <img src="https://2019.igem.org/wiki/images/4/4d/T--Tuebingen--Biohacking_10.jpg"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder"></a>
+
                                 alt="Placeholder"></a>
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 8. 08/14/19 Colony PCR of psB1C3_K1
+
                     </figure>
                        transformation. Gel loaded (from left to right): Ladder 1kb, psB1C3_K0 1-10.</figcaption>
+
        </div>
          </figure>
+
                     </div>
          <figure>
+
                    <p>
                        <a style="font-size: small"
+
                        A lot of questions were asked during the <a href="https://2019.igem.org/wiki/images/1/13/T--Tuebingen--Panel_discussion_allg.pdf" onclick='window.open("https://2019.igem.org/wiki/images/1/13/T--Tuebingen--Panel_discussion_allg.pdf","_self");'>panel discussion</a> and the presentation. We discussed
                          href="https://2019.igem.org/wiki/images/c/cc/T--Tuebingen--Gel9.png"
+
                         the ethical implications of the CRISPR / Cas Method with the audience. Surprisingly,
                          data-effect="mfp-zoom-out"
+
                         many participants were eager to talk about scenarios they have heard about.
                          title="Some title">
+
                     </p>
                            <img src="https://2019.igem.org/wiki/images/c/cc/T--Tuebingen--Gel9.png"
+
                </div>
                                class="figure-img img-fluid rounded"
+
            </div>
                                alt="A generic square placeholder image"></a>
+
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 9. 08/15/19 Digestions after Miniprep.
+
                        Gel loaded (from left to right): Ladder 1kb, psB1C3_K6 1, empty, psB1C3_K6 2, psB1C3_K3 1-2, K10_Cas3
+
                        1-2, K10_Cascade 1-2, BBa_R0073(Mnt)_RFP 1-4. K6 expected at ~2 kb and 1.5 kb, K3 expected at
+
                        ~2 kb and 1 kb, Cas3 expected at ~2.4 kb, ~2 kb and ~0.3 kb, Cascade expected at ~5.1 kb, ~1,2 kb
+
                        and ~0.3 kb, RFP expected at ~2 kb and ~1 kb. </figcaption>
+
          </figure>
+
      </div>
+
    </div>
+
  </div>
+
</div>
+
                <div id="accordion7">
+
  <div class="card">
+
    <div class="card-header" id="headingSeven">
+
      <h5 class="mb-0">
+
        <button class="btn btn-one btn-link collapsed" data-toggle="collapse" data-target="#collapseSeven" aria-expanded="false" aria-controls="collapseSeven">
+
          Week 7 (19 Aug - 23 Aug)
+
        </button>
+
      </h5>
+
    </div>
+
    <div id="collapseSeven" class="collapse" aria-labelledby="headingSeven" data-parent="#accordion7" >
+
      <div class="card-body" style="background-color: #232323;">
+
          <p style="color: #F4F0DE">
+
              19 Patrick Jakob Eva After respective digestion and DNA clean up, psB1C3_K1, psB1C3_K3, psB1C3_K7 and
+
              K5_K4 were ligated. The BBa_R0073(Mnt)_RFP plasmid was digested to isolate Mnt_RFP by gel extraction
+
              (figure 10). The backbone pSB1K3 was digested with respective enzymes and pSB1K3_Mnt_RFP was ligated.
+
              K1, K2, K3, K4, K7 and K15 were amplified via PCR (Q5 polymerase) with a new programm. 20 Eva Patrick
+
              Last weeks psBC13_K6, K10_Cas3 and K10_Cascade were sent off to Sanger sequencing. Yesterday’s ligations
+
              were transformed as well as K10_Cascade retransformed. 21 Marie Zoe Patrick A new batch of competent cells
+
              was prepared and overnight cultures of psB1C3_K1, psB1C3_K7, K5_K4 and K10_Cascade inoculated. 22 Patrick
+
              Eva Sanger Sequencing was positive on K10_Cascade. Chloramphenicol and Kanamycin plates were prepared.
+
              After Miniprep of psB1C3_K1, psB1C3_K7, K5_K4 and K10_Cascade the plasmids were digested and run on a gel.
+
              Digestions of psB1C3_K1 and K5_K4 were negative. The new competent cells were transformed with psB1C3_K3,
+
              psB1K3_Mnt_RFP and iGEM competent cell test plasmids. 23 Marie Patrick The constructs K1, K2, K3, K4, K7
+
              and K15 were amplified by PCR (Q5 polymerase). Double digestion of psB1C3_K7 and K10_Cascade was repeated.
+
              The gel electrophoresis suggested XY (figure 11).
+
          </p>
+
          <figure>
+
                        <a style="font-size: small"
+
                          href="https://2019.igem.org/wiki/images/7/77/T--Tuebingen--Gel10.png"
+
                          data-effect="mfp-zoom-out"
+
                          title="Some title">
+
                            <img src="https://2019.igem.org/wiki/images/7/77/T--Tuebingen--Gel10.png"
+
                                class="figure-img img-fluid rounded"
+
                                alt="A generic square placeholder"></a>
+
                    <figcaption style="color: #F4F0DE; font-size: small;">Figure 10. 08/19/19 Digestion of BBa_R0073(Mnt)_RFP
+
                         for gel extraction. Gel loaded (from left to right): Ladder 1 kb, BBa_R0073(Mnt)_RFP.
+
                         Desired fragment at ~0.5 kb.</figcaption>
+
          </figure>
+
          <figure>
+
                        <a style="font-size: small"
+
                          href="https://2019.igem.org/wiki/images/9/92/T--Tuebingen--Gel11.png"
+
                          data-effect="mfp-zoom-out"
+
                          title="Some title">
+
                            <img src="https://2019.igem.org/wiki/images/9/92/T--Tuebingen--Gel11.png"
+
                                class="figure-img img-fluid rounded"
+
                                alt="A generic square placeholder image"></a>
+
                     <figcaption style="color: #F4F0DE; font-size: small;">Figure 11. Digestion after Miniprep.
+
                        Gel loaded (from left to right): Ladder 1 kb, psB1C3_K7 1-2, K10_Cascade 1-5, K10_Cas3.</figcaption>
+
          </figure>
+
      </div>
+
    </div>
+
  </div>
+
</div>
+
</div>
+
  
 +
            <h3 style="font-family:'Righteous'; color:#2ecc71;">Outlook - Advisors of the Experimenta iGEM team 2020 & New student lab course</h3>
 +
            <div class="row">
 +
                <div class="col-12">
 +
                    <p>During the collaboration with the Experimenta Heilbronn, we sat together with Dr. Robert Friedrich
 +
                        and Norbert Hommrichhausen to discuss the foundation of an iGEM high school team at the Experimenta
 +
                        Heilbronn. The Experimenta is highly interested in starting a team in Heilbronn and the motivated
 +
                        and interested students encouraged us to team up and further pursue this plan. Plans for an iGEM
 +
                        high school team 2020 were made, in which the Experimenta Heilbronn will be the main partner
 +
                        providing lab space, supervision and funding. The role of the iGEM Team Tuebingen is that of
 +
                        experienced advisors, who can assist in questions concerning the iGEM competition itself, the
 +
                        workflow of an iGEM year, as well as deliver expert knowledge and guidance in the laboratory or
 +
                        in questions concerning bioinformatics, design and human practices. Both the Experimenta and the
 +
                        iGEM Team Tuebingen aim at establishing a long-term collaboration in the scope of iGEM.</p>
  
 
+
                     <p>
        </div>
+
                         Next to the foundation of a high school iGEM team, the Experimenta will also introduce new lab
 
+
                         courses for school classes, one of them being a CRISPR/Cas course. The theoretical background,
          <div id="glpreferences" class="row">
+
                         first steps and foundation of this course arose from the collaboration with iGEM Tuebingen this year.
                <h3 style="font-family:'Righteous'; color: #2ecc71;">References</h3>
+
                         A more detailed outline and implementation of the course will be part of another collaboration
                <div class="col-12" style="font-size: x-small; overflow-wrap: break-word;">
+
                         between the Experimenta and iGEM Tuebingen.
                     <ol>
+
                     </p>
                         <li style="color: #F4F0DE"><a href=https://doi.org/10.1093/femsle/fnw212> Ulrich Sonnenborn, Escherichia coli strain Nissle 1917—from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties, FEMS Microbiology Letters, Volume 363, Issue 19, October 2016, fnw212,</a></li>
+
                         <li id="ref_2" style="color: #F4F0DE">Sana Ben Othman and Tomio Yabe. Use of Hydrogen Peroxide and Peroxl Radicals to induce Oxidative Stress in Neuronal Cells. Reviews in Agricultural Science, 3:40-45, 2015. Doi: 10.7831/ras.3.40</li>
+
                        <li id="ref_3" style="color: #F4F0DE;">P. Capela, T.K.C. Hay, N.P. Shah. Effect of cryoprotectants, prebiotics and microencapsulation on survival of probiotic organisms in yoghurt and freeze-dried yoghurt. Food Research International. Volume 39, Issue 2, 2006, Pages 203-211, ISSN 0963-9969, https://doi.org/10.1016/j.foodres.2005.07.007.</li>
+
                        <li id="ref_4" style="color: #F4F0DE;">Govender M, Choonara YE, Kumar P, du Toit LC, van Vuuren S, Pillay V. A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech. 2014;15(1):29–43. doi:10.1208/s12249-013-0027-1</li>
+
                         <li id="ref_5" style="color: #F4F0DE;"><a href="https://opsdiagnostics.com/applications/lyophilization/ecoli_lyophilization_stability.html">https://opsdiagnostics.com/applications/lyophilization/ecoli_lyophilization_stability.html</a> </li>
+
                        <li id="ref_6" style="color: #F4F0DE;"><a href="https://doi.org/10.1007/s00125-008-1053-5"></a>Bailey, C. J, Wilcock, C, Scarpello, J. H. B. Metformin and the intestine. Diabetologia. 2008.  Volume 51, Issue 8, Pages 1552, ISSN 1432-0428, Doi: 10.1007/s00125-008-1053-5,</li>
+
                        <li id="ref_7" style="color: #F4F0DE;">High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome. Paleari, LauraBurhenne, JürgenFoersch, SebastianParodi, AndreaGnant, MichaelScherer, DominiqueUlrich, Cornelia M.Stabuc, BorutPuntoni, MatteoCoccia, GianniPetrera, MarilenaHaefeli, Walter-EmilDeCensi, Andrea et al. Gastroenterology, Volume 154, Issue 5, 1543 - 1545</li>
+
                         <li id="ref_8" style="color: #F4F0DE;">Martinez-Augustin O, Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J Gastroenterol. 2008;14(37):5630–5640. doi:10.3748/wjg.14.5630</li>
+
                        <li id="ref_9" style="color: #F4F0DE;">Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. T. C. NORTHFIELD AND I. McCOLL. Gut, 1973, 14, 513-518</li>
+
                         <li id="ref_10" style="color: #F4F0DE;">Belizário JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015;6:1050. Published 2015 Oct 6. doi:10.3389/fmicb.2015.01050</li>
+
                        <li id="ref_11" style="color: #F4F0DE;">Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. Published 2016 Apr 27. doi:10.1186/s13073-016-0307-y</li>
+
                     </ol>
+
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
 +
        </div>
 
     </main>
 
     </main>
 +
</div>
 
</div>
 
</div>
  

Latest revision as of 21:49, 19 October 2019

GLP.exe

Experimenta

The Experimenta Science Center Heilbronn

The Experimenta Science Center (Experimenta) in Heilbronn, Baden-Wuerttemberg, Germany offers science at your fingertips on an area of around 25,000 square metres with around 275 interactive exhibits, four creative studios and nine laboratories, as well as an observatory and an extraordinary science dome with spectacular science shows. Additionally, last year, they set up the “Schülerforschungszentrum” (SFZ), where young researchers are actively supported in their initial scientific work. It is directed at students from high schools in Heilbronn. Their general idea is to encourage students to develop their own projects while funding, lab space and supervision is granted.

Our 4 Day Lab Course

The course was held in a collaborative manner over a span of four days. Dr. Robert Friedrich, a biologist working for the SFZ, gave the general lab introduction and provided the overall lab responsibility, while we were mainly responsible to teach the required theoretical background, introduce bioinformatics data analysis (DNA-Seq) and finally project development. Additionally, we were supporting Dr. Friedrich during the experiments and closely supervised the students.

We conveyed the required theoretical background in a modern and interactive way, with the use of smart boards and current web tools. We focused on teaching the highly motivated students cutting-edge research, while providing a theoretical foundation, preparing them for different biology competitions and eventually university.

Please check out the material we prepared for the course - a script covering all the theoretical background and a presentation:

Please see the schedule below.

Due to the interactive design of the course, we also discussed the experiments with the students and tried to summarize what we did on the blackboard:

The students were also very interested in iGEM and our work. Hence, we not only introduced iGEM and our project to them, but also let them critically evaluate our project. They were also given the chance to conduct PCRs related to our project and could therefore gain insights into the upcoming challenges when starting a new project or experiment where not everything has been optimised for easy functionality. Many students were interested in the iGEM competition itself and in the process of finding a project and making it feasible. Therefore, we also invested into giving valuable input and advice on starting a project and encouraged the students to participate in iGEM or similar projects themselves. Several questions and concerns relating the functionality of our probiotic under different conditions, such as patients taking medications or antibiotics were also raised by the students. These fruitful discussions, as well as our exchange with several experts, contributed to the final design of our RNA-Seq experiment providing valuable input and different aspects to be considered [Experts, Nissle].

Due to the high interest of the students and the positive feedback from the Experimenta itself, we discussed the possibility of creating an iGEM high school team in Heilbronn in 2020. The Experimenta is highly interested in participating in iGEM 2020 with motivated students and will provide the required laboratories, supervision and funding. Our team will still be serving as advisors for the planned iGEM high school team next year. Furthermore, a new student lab course on CRISPR/Cas will be introduced at the Experimenta on the grounds of the theoretical background, input and inspiration iGEM Tuebingen conveyed.

Panel Discussion - „Biohacking – genetic experiments done at home“

In addition to the lab course, we also decided to host a panel discussion at the Experimenta. At the beginning of the panel discussion, we gave a talk about on the CRISPR / Cas method itself. We also included an overview of our ongoing project and the iGEM competition in general.

In collaboration with Dr. Robert Friedrich, we designed a discussion around the status of current research on CRISPR / Cas, the effectiveness of the method and its limitations, the prospects of future CRISPR / Cas developments, the availability and legality of so-called Do-It-Yourself CRISPR / Cas Kits and the ethical implications on society. The panel consisted out of Prof. Dr. Christoph Thyssen (Christoph Thyssen), an expert for subject didactics in biology and two of our team members - Marietheres Evers and Famke Baeuerle.

A lot of questions were asked during the panel discussion and the presentation. We discussed the ethical implications of the CRISPR / Cas Method with the audience. Surprisingly, many participants were eager to talk about scenarios they have heard about.

Outlook - Advisors of the Experimenta iGEM team 2020 & New student lab course

During the collaboration with the Experimenta Heilbronn, we sat together with Dr. Robert Friedrich and Norbert Hommrichhausen to discuss the foundation of an iGEM high school team at the Experimenta Heilbronn. The Experimenta is highly interested in starting a team in Heilbronn and the motivated and interested students encouraged us to team up and further pursue this plan. Plans for an iGEM high school team 2020 were made, in which the Experimenta Heilbronn will be the main partner providing lab space, supervision and funding. The role of the iGEM Team Tuebingen is that of experienced advisors, who can assist in questions concerning the iGEM competition itself, the workflow of an iGEM year, as well as deliver expert knowledge and guidance in the laboratory or in questions concerning bioinformatics, design and human practices. Both the Experimenta and the iGEM Team Tuebingen aim at establishing a long-term collaboration in the scope of iGEM.

Next to the foundation of a high school iGEM team, the Experimenta will also introduce new lab courses for school classes, one of them being a CRISPR/Cas course. The theoretical background, first steps and foundation of this course arose from the collaboration with iGEM Tuebingen this year. A more detailed outline and implementation of the course will be part of another collaboration between the Experimenta and iGEM Tuebingen.